Skip to main navigation
CareDx
  • COMPANY
    • Management Team
    • Board of Directors
    • Compliance
    • Careers
      • Current Openings
      • Benefits
  • PRODUCTS
    • HeartCare, AlloMap
    • KidneyCare, AlloSure
    • Laboratory Products
    • Ottr
  • INVESTORS
  • CONTACT US

Press Releases

Media Inquiries - media@caredx.com

Date Title and Summary Additional Formats
Toggle Summary Mar 24, 2014 XDx Announces Appointment of Kenneth E. Ludlum as Chief Financial Officer View HTML
Toggle Summary Mar 28, 2014 XDx Announces Name Change to CareDx View HTML
Toggle Summary Apr 25, 2014 CareDx Announces Appointment of George W. Bickerstaff to Its Board of Directors View HTML
Toggle Summary Jun 03, 2014 CareDx Files Registration Statement for Proposed Initial Public Offering View HTML
Toggle Summary Jun 11, 2014 CareDx Completes Acquisition of ImmuMetrix View HTML
Toggle Summary Jun 16, 2014 CareDx and Illumina Enter into Supply Agreement for Next Generation Sequencing Technologies View HTML
Toggle Summary Jul 17, 2014 CareDx Announces Pricing of its IPO and Completion of its First Day of Trading
CareDx Announces Pricing of its IPO and Completion of its First Day of Trading Brisbane, CA July 17, 2014 CareDx, Inc. (NASDAQ: CDNA) announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $10 per share, before underwriter discounts.
View HTML
CareDx Announces Pricing of its IPO and Completion of its First Day of Trading 11.8 KB
Toggle Summary Jul 28, 2014 CareDx Presents Cell-Free DNA Biomarker Results in Heart and Kidney Transplant Recipients at the World Transplant Congress
Graft-Derived cfDNA in Bloodstream Correlates to Acute Cellular Rejection in Kidney as Well as in Heart Transplant Recipients
View HTML
CareDx Presents Cell-Free DNA Biomarker Results in Heart and Kidney Transplant Recipients at the World Transplant Congress 22.1 KB
Toggle Summary Jul 31, 2014 CareDx and Allegheny General Hospital Launch Research Study of Novel Test to Screen Heart Transplant Recipients for Signs of Rejection
BRISBANE, Calif. and PITTSBURGH , July 31, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA) a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients and Allegheny
View HTML
CareDx and Allegheny General Hospital Launch Research Study of Novel Test to Screen Heart Transplant Recipients for Signs of Rejection 26.4 KB
Toggle Summary Aug 14, 2014 CareDx to Release Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 27, 2014
BRISBANE, Calif. , Aug. 14, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today announced that it will
View HTML
CareDx to Release Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 27, 2014 17.7 KB

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Next page Next
  • Last page Last
Displaying 1 - 10 of 383 results

Investor Relations

  • Investor Relations
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

Printed Materials
E-mail Alerts
Downloads
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

    ©2004-2022 CareDx, Inc. All Rights Reserved.    CareDx is a registered trademark of CareDx, Inc.

    Privacy & Compliance